ATE369363T1 - Antibiotika mit doppelwirkung - Google Patents

Antibiotika mit doppelwirkung

Info

Publication number
ATE369363T1
ATE369363T1 AT02796533T AT02796533T ATE369363T1 AT E369363 T1 ATE369363 T1 AT E369363T1 AT 02796533 T AT02796533 T AT 02796533T AT 02796533 T AT02796533 T AT 02796533T AT E369363 T1 ATE369363 T1 AT E369363T1
Authority
AT
Austria
Prior art keywords
antibiotics
dual effect
dual
effect
compounds
Prior art date
Application number
AT02796533T
Other languages
English (en)
Inventor
Christian Hubschwerlen
Jean-Luc Specklin
Original Assignee
Morphochem Ag Komb Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphochem Ag Komb Chemie filed Critical Morphochem Ag Komb Chemie
Application granted granted Critical
Publication of ATE369363T1 publication Critical patent/ATE369363T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02796533T 2001-10-04 2002-10-04 Antibiotika mit doppelwirkung ATE369363T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32716201P 2001-10-04 2001-10-04

Publications (1)

Publication Number Publication Date
ATE369363T1 true ATE369363T1 (de) 2007-08-15

Family

ID=23275422

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02796533T ATE369363T1 (de) 2001-10-04 2002-10-04 Antibiotika mit doppelwirkung

Country Status (21)

Country Link
US (2) US7820823B2 (de)
EP (1) EP1432705B1 (de)
JP (2) JP4398245B2 (de)
KR (2) KR100927864B1 (de)
CN (2) CN1630655A (de)
AT (1) ATE369363T1 (de)
AU (1) AU2002361948B2 (de)
BR (1) BRPI0213063B8 (de)
CA (1) CA2460572C (de)
CY (1) CY1107503T1 (de)
DE (1) DE60221684T2 (de)
DK (1) DK1432705T3 (de)
ES (1) ES2287354T3 (de)
HK (1) HK1128469A1 (de)
HU (1) HU229935B1 (de)
IL (2) IL160769A0 (de)
NZ (1) NZ531879A (de)
PL (1) PL210850B1 (de)
PT (1) PT1432705E (de)
WO (2) WO2003031443A1 (de)
ZA (1) ZA200401909B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60205030T2 (de) 2001-09-11 2006-04-20 Astrazeneca Ab Oxazolidinon- und/oder isoxazolinderivate als antibakterielle mittel
WO2003031443A1 (de) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual action antibiotics
BRPI0409955A (pt) * 2003-04-30 2006-04-25 Morphochem Ag Komb Chemie uso de antibióticos hìbridos de oxazolidinona - quinolina para o tratamento de antrax e outras infecções
WO2004101552A1 (en) * 2003-05-14 2004-11-25 Orchid Chemicals & Pharmaceuticals Ltd Oxazolidinone derivatives as antibacterial agents
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
KR101176450B1 (ko) * 2003-12-18 2012-08-30 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 옥사졸리디논-퀴놀론 혼성 항생제
EP1557416A1 (de) * 2004-01-23 2005-07-27 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Oxazolidinon-Chinolon Hybrid Antibiotika
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
WO2005111030A1 (en) * 2004-05-12 2005-11-24 Warner-Lambert Company Llc Quinolone antibacterial agents
US20060105941A1 (en) * 2004-11-12 2006-05-18 Allergan, Inc. Mixed antibiotic codrugs
GB0505969D0 (en) 2005-03-23 2005-04-27 Novartis Ag Organic compounds
AR054608A1 (es) 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
BRPI0620736A2 (pt) 2005-12-30 2011-12-20 Novartis Ag compostos orgánicos
US7456279B2 (en) * 2006-03-28 2008-11-25 The Procter & Gamble Company Coupling process for preparing quinolone intermediates
EP2181994B1 (de) 2006-03-31 2014-05-28 Research Foundation Itsuu Laboratory Antimikrobielle Verbindungen
US8124623B2 (en) 2006-11-10 2012-02-28 Actelion Pharmaceuticals Ltd. 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
CL2007003332A1 (es) 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
KR101238479B1 (ko) 2007-06-25 2013-03-04 노파르티스 아게 레닌 억제제로 사용하기 위한 n5-(2-에톡시에틸)-n3-(2-피리디닐)-3,5-피페리딘디카르복스아미드 유도체
US8637513B2 (en) * 2007-10-24 2014-01-28 Merck Sharp & Dohme Corp. Heterocycle phenyl amide T-type calcium channel antagonists
NZ589734A (en) * 2008-05-09 2012-11-30 Actelion Pharmaceuticals Ltd 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases
WO2010081851A1 (en) 2009-01-14 2010-07-22 Genoscience Pharma Piperidin-4-ylpiperazine compounds for the treatment of hcv infection
CA2903435A1 (en) 2013-03-08 2014-09-12 Allergan Inc. Antibiotic conjugates directly linked with steroid drugs
WO2014138437A1 (en) 2013-03-08 2014-09-12 Allergan, Inc. Steroid conjugates
CN103145615B (zh) * 2013-03-20 2015-07-29 浙江医药股份有限公司 一种奈诺沙星螯合物的后处理方法
BR112015029488A8 (pt) 2013-05-28 2019-12-17 Morphochem Aktiengesellschaft Fuer Komb Chemie híbridos de oxazolidinonaquinolona, e seus usos no tratamento parentérico ou na profilaxia de doenças bacterianas
KR102242998B1 (ko) 2013-05-28 2021-04-21 모르포켐 게엠베하 박테리아 감염 치료의 용도를 위한 옥사졸리디논-퀴놀론을 포함하는 병용 용법
CN103421008B (zh) * 2013-09-07 2015-05-27 吉首大学 一类多靶点呋喃酮-喹啉酮型化合物及其制法和用途
CN107286182A (zh) * 2016-04-12 2017-10-24 李靖 新型噁唑烷酮‑氟喹诺酮衍生物及用途
CN107648181B (zh) * 2016-07-25 2021-05-04 广东赛法洛药业有限公司 一种利他唑酮磷脂复合物及其制备方法和应用
US10087171B2 (en) 2016-12-19 2018-10-02 Actelion Pharmaceuticals Ltd Crystalline forms of cadazolid
CN109942546B (zh) * 2019-04-16 2022-04-08 西南大学 喹诺酮嘧啶类化合物及其制备方法和应用
AR127435A1 (es) * 2021-10-26 2024-01-24 Hoffmann La Roche Compuestos piperazinilsulfonilarilo para el tratamiento de infecciones bacterianas

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840956A (en) * 1986-02-18 1989-06-20 Warner-Lambert Company Novel disubstituted-7-pyrrolidinoquinoline antibacterial agents
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH0269478A (ja) 1988-09-05 1990-03-08 Sagami Chem Res Center キノロンカルボン酸誘導体
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
ATE123494T1 (de) 1989-03-30 1995-06-15 Wakunaga Seiyaku Kk Chinolon-derivate und deren salze, verfahren zu deren herstellung und diese enthaltende antibakterielle wirkstoffe.
ATE146783T1 (de) * 1991-11-01 1997-01-15 Upjohn Co Substituierte aryl- und heteroaryl- phenyloxazolidinone
US5221676A (en) * 1992-02-06 1993-06-22 Warner-Lambert Company 7-substituted quinolones and naphthyridones as antibacterial agents
CA2232728C (en) 1995-09-22 2003-11-04 Wakunaga Pharmaceutical Co., Ltd. Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
DE19601265A1 (de) 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
DE19633480A1 (de) 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
GB9725244D0 (en) * 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
BR9907183A (pt) 1998-01-23 2003-06-10 Versicor Inc Colet neas combinatórias de oxazolidinona, composições e processos de preparação
TW572757B (en) 1998-08-24 2004-01-21 Bristol Myers Squibb Co Novel isoxazolinone antibacterial agents
KR100324621B1 (ko) 1999-04-27 2002-02-27 박호군 퀴놀론이 치환된 옥사졸리디논 유도체 및 그의 제조 방법과 항균제로서의 용도
NZ516853A (en) 1999-07-28 2003-11-28 Upjohn Co Oxazolidinones and their use as anti-infectives
US6518285B2 (en) 1999-12-21 2003-02-11 Ortho Mcneil Pharmaceutical, Inc. Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
ATE319710T1 (de) 2000-12-21 2006-03-15 Pharmacia & Upjohn Co Llc Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
ES2186550B2 (es) 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.
WO2003031443A1 (de) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual action antibiotics
WO2003031441A1 (en) 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
US20040132764A1 (en) * 2002-10-23 2004-07-08 Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie Antibiotics for the treatment of infections in acidic environments
WO2004069816A1 (en) 2003-02-07 2004-08-19 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
BRPI0409955A (pt) * 2003-04-30 2006-04-25 Morphochem Ag Komb Chemie uso de antibióticos hìbridos de oxazolidinona - quinolina para o tratamento de antrax e outras infecções
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
KR101176450B1 (ko) 2003-12-18 2012-08-30 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 옥사졸리디논-퀴놀론 혼성 항생제
US8158797B2 (en) * 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
AR054608A1 (es) 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
KR200430712Y1 (ko) 2006-08-30 2006-11-13 명 식 신 천장등
AU2007318901B2 (en) 2006-11-10 2013-03-14 Actelion Pharmaceuticals Ltd 5-hydroxymethyl-oxazolidin-2-one derivatives
US8124623B2 (en) * 2006-11-10 2012-02-28 Actelion Pharmaceuticals Ltd. 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
CL2007003332A1 (es) 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
NZ589734A (en) 2008-05-09 2012-11-30 Actelion Pharmaceuticals Ltd 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases

Also Published As

Publication number Publication date
NZ531879A (en) 2005-10-28
HU229935B1 (en) 2015-01-28
CN101381365B (zh) 2011-07-06
PT1432705E (pt) 2007-08-27
WO2003032962A2 (en) 2003-04-24
PL210850B1 (pl) 2012-03-30
EP1432705B1 (de) 2007-08-08
CA2460572A1 (en) 2003-04-24
KR20090100426A (ko) 2009-09-23
CY1107503T1 (el) 2013-03-13
KR100927864B1 (ko) 2009-11-23
CN101381365A (zh) 2009-03-11
BR0213063A (pt) 2004-09-28
DE60221684T2 (de) 2008-04-30
IL160769A0 (en) 2004-08-31
PL367517A1 (en) 2005-02-21
BRPI0213063B8 (pt) 2021-05-25
WO2003032962A3 (en) 2003-07-17
US20110059946A1 (en) 2011-03-10
ES2287354T3 (es) 2007-12-16
US20050096343A1 (en) 2005-05-05
DK1432705T3 (da) 2007-09-17
JP2010006814A (ja) 2010-01-14
KR20040055781A (ko) 2004-06-26
BRPI0213063B1 (pt) 2018-02-14
JP4398245B2 (ja) 2010-01-13
DE60221684D1 (de) 2007-09-20
JP2005529061A (ja) 2005-09-29
WO2003031443A1 (de) 2003-04-17
CA2460572C (en) 2011-11-08
KR100987696B1 (ko) 2010-10-13
US8329908B2 (en) 2012-12-11
IL160769A (en) 2009-12-24
EP1432705A2 (de) 2004-06-30
CN1630655A (zh) 2005-06-22
HUP0402126A3 (en) 2012-10-29
HUP0402126A2 (hu) 2005-02-28
HK1128469A1 (en) 2009-10-30
AU2002361948B2 (en) 2007-03-29
US7820823B2 (en) 2010-10-26
ZA200401909B (en) 2005-05-25

Similar Documents

Publication Publication Date Title
ATE369363T1 (de) Antibiotika mit doppelwirkung
HK1090647A1 (en) Oxazolidinone-quinolone hybrid antibiotics
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
NO20052787D0 (no) N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ATE311209T1 (de) Kombinationen von antiseptischen und antibiotischen mitteln enthaltende medizinische vorrichtungen
SE0000540D0 (sv) New compounds
DE60135919D1 (de) Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
HRP20050517B1 (hr) N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
GB0127903D0 (en) Improvements relating to organic compounds
ATE433963T1 (de) Fab-i inhibitoren
BR0010982A (pt) Novas oxazolidinonas bicìclicas como agentes antibacterianos
SE9801494D0 (sv) Novel use
DOP2002000371A (es) Fenil-heterociclil-eteres
ATE368025T1 (de) Pleuromutilinderivate mit antimikrobieller wirkung
BR0313400A (pt) N-aril-2-oxazolidinonas e seus derivados
CY1110139T1 (el) Γλυκοπεπτιδικα αντιβιοτικα